Tan, Sheng-Lan
Xiao, Jie
Yuan, Hai-Yan
Chen, Lei
Wang, Qing
Xiang, Da-Xiong
Li, Xia
Zhou, Yan-Gang
Guo, Yan
Huang, Hai-Ying
Zhao, Dan-Hui
Li, Yue
Wang, Li
Li, Qun
Liu, Juan
Xu, Ping http://orcid.org/0000-0001-8692-0219
Funding for this research was provided by:
China Medical Board (18-292)
Hunan Provincial Health Commission (2019158)
Article History
Received: 24 January 2022
Accepted: 18 February 2022
First Online: 4 March 2022
Declarations
:
: The corresponding author is the principle investigator of the study and the Second Xiangya Hospital is the coordinating center of the study. The Clinical Research Ethics Committee of the Second Xiangya Hospital of Central South University, who monitors all human research conducted by stuff in the Second Xiangya Hospital, has reviewed and approved this study protocol (No. 2019–213). Among the six participated primary hospitals, only the First People's Hospital of Yueyang has an independent medical ethics committee in their hospital, who has also reviewed and approved this study protocol (No. 2020–001). The other five participated primary hospitals (Taoyuan People's Hospital, The People's Hospital of Liuyang, The First People's Hospital of Pingjiang, People's Hospital of Ningxiang, The Second People's Hospital of Huaihua) accepted and used the ethics approval from the Second Xiangya Hospital as their ethics approval. Each of the enrolled eligible patients will sign and get a copy of the informed consent form.
: Not applicable.
: The authors declare that they have no competing interests.